Investigation of a cluster of Legionnaires’ disease during the outbreak of coronavirus disease 2019 pandemic in northeastern Taiwan, June 2021

Ye, Jung-Jr; Zheng, Jun-Yuan; Chen, Ya-Hsuan; Kao, Ya-Ling; Kao, Yi Chin; Chao, Shao-Wen

doi:10.1016/j.jmii.2022.04.008

Cited by 1 publication

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the COVID-19 pandemic, all pneumonia patients must be admitted via emergency room to isolated wards and tested for COVID-19 repeatedly. As indicated by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) guidelines for CAP, only severe cases should be tested with the Legionella urinary antigen test or those with epidemiological indications [ 31 ]. Despite the fact that the cumulative prevalence of 0.288% in the entirety of SARS-CoV-2 cases may appear quite irrelevant, it would correspond to an unprecedented number of diagnoses for Legionella infections in the general population.…”

Section: Discussionmentioning

confidence: 99%

Legionellosis-Associated Hospitalization in Spain from 2002 to 2021

et al. 2023

View full text Add to dashboard Cite

Legionellosis is a respiratory disease of bacterial and environmental origin that usually presents two distinct clinical entities, “Legionnaires’ disease” (LD) and “Pontiac fever”. LD is an important cause of hospital-acquired pneumonia (HAP). The objective of this study is to describe the epidemiology of legionellosis-associated hospitalization (L-AH) in Spain from 2002 to 2021 and the burden of hospitalization due to legionellosis. Discharge reports from the Minimum Basic Data Set (MBDS) were used to retrospectively analyze hospital discharge data with a diagnosis of legionellosis, based on the ICD-9-CM and ICD-10-CM diagnosis codes, from 2002 to 2021. 21,300 L-AH occurred throughout the year during 2002–2021. The incidence of hospitalization associated per 100,000 inhabitants by month showed a similar trend for the 2002–2011, 2012–2021, and 2002–2021 periods. In Spain, during 2002–2021, the hospitalization rate (HR) in the autonomous communities ranged from 4.57 (2002–2011) to 0.24 (2012–2021) cases per 100,000 inhabitants. The HR of legionellosis in Spain has substantially increased across the 2002–2021 period, and the estimate is consistent with available European data. It is considered that in-depth epidemiological surveillance studies of legionellosis and improvements in the prevention and control of the disease are required in Spain.

show abstract

Section: Discussionmentioning

confidence: 99%